Loading...

A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study

Saved in:
Bibliographic Details
Published in:Drug Des Devel Ther
Main Authors: Spagnuolo, Vincenzo, Galli, Laura, Poli, Andrea, Bigoloni, Alba, Fumagalli, Luca, Gianotti, Nicola, Nozza, Silvia, Ferrari, Davide, Locatelli, Massimo, Lazzarin, Adriano, Castagna, Antonella
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2019
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6352870/
https://ncbi.nlm.nih.gov/pubmed/30774311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S192124
Tags: Add Tag
No Tags, Be the first to tag this record!